n.a. (WX)

0.00
NYSE
Prev Close 0.00
Day Low/High 0.00 / 0.00
52 Wk Low/High 0.00 / 0.00
Exchange NYSE
Div & Yield N.A. (N.A)
4 Health Services Stocks On The Rise

4 Health Services Stocks On The Rise

TheStreet highlights 4 stocks pushing the health services industry higher today.

3 Health Care Stocks Rising on Big Volume

3 Health Care Stocks Rising on Big Volume

Often when above-average volume moves into an equity, it precedes a large spike in volatility.

4 Stocks Rising on Unusual Volume

4 Stocks Rising on Unusual Volume

Often when above-average volume moves into an equity, it precedes a large spike in volatility.

4 Stocks Pushing The Health Services Industry Higher

4 Stocks Pushing The Health Services Industry Higher

TheStreet Ratings group would like to highlight 4 stocks pushing the health services industry higher today, Nov. 30, 2012.

WuXi PharmaTech (Cayman) Management Discusses Q2 2012 Results - Earnings Call Transcript

WuXi PharmaTech (Cayman) Management Discusses Q2 2012 Results - Earnings Call Transcript

WuXi PharmaTech (Cayman) Management Discusses Q2 2012 Results - Earnings Call Transcript

Can Netflix Stay Afloat?

Can Netflix Stay Afloat?

As with RIM, the media company is starting to feel the pressure that comes with being a market leader.

WuXi PharmaTech (Cayman) Inc. Stock Upgraded (WX)

WuXi PharmaTech (Cayman) Inc. Stock Upgraded (WX)

WuXi PharmaTech (Cayman (NYSE:WX) has been upgraded by TheStreet Ratings from a hold to buy.

WuXi PharmaTech (Cayman Stock Hits New 52-Week Low (WX)

WuXi PharmaTech (Cayman Stock Hits New 52-Week Low (WX)

WuXi PharmaTech (Cayman (NYSE:WX) hit a new 52-week low Monday as it is currently trading at $10.84, below its previous 52-week low of $10.95 with 11,161 shares traded as of 9:56 a.m. ET. Average volume has been 277,600 shares over the past 30 days.

WuXi PharmaTech (Cayman Stock Hits New 52-Week Low (WX)

WuXi PharmaTech (Cayman Stock Hits New 52-Week Low (WX)

WuXi PharmaTech (Cayman (NYSE:WX) hit a new 52-week low Friday as it is currently trading at $11.01, below its previous 52-week low of $11.03 with 106,405 shares traded as of 1:46 p.m. ET. Average volume has been 453,500 shares over the past 30 days.

WuXi PharmaTech (Cayman) Inc. Stock Downgraded (WX)

WuXi PharmaTech (Cayman) Inc. Stock Downgraded (WX)

WuXi PharmaTech (Cayman (NYSE:WX) has been downgraded by TheStreet Ratings from from a buy to hold.

8 Biotech Stocks to Watch

8 Biotech Stocks to Watch

These biotech industry stocks have upside potential of 8% to 62%, based on analysts' estimates and company fundamentals.

WuXi PharmaTech (Cayman Reaches New 52-Week High (WX)

WuXi PharmaTech (Cayman Reaches New 52-Week High (WX)

WuXi PharmaTech (Cayman (NYSE:WX) hit a new 52-week high Monday as it is currently trading at $18.82, above its previous 52-week high of $18.80 with 147,783 shares traded as of 10:52 a.m. ET. Average volume has been 454,500 shares over the past 30 days.

10 Health Care Stocks With Upside: Analysts

10 Health Care Stocks With Upside: Analysts

Gentium, Concord Medical and ShangPharma are stocks that could deliver up to 72% as per consensus estimates.

Emerging-Market ADRs: Winners and Losers

Emerging-Market ADRs: Winners and Losers

Chinese Internet stocks and Brazilian utilities were among emerging-market winners last week.

WuXi PharmaTech (Cayman) Inc. Stock Downgraded (WX)

WuXi PharmaTech (Cayman) Inc. Stock Downgraded (WX)

WuXi PharmaTech (Cayman (NYSE:WX) has been downgraded by TheStreet Ratings from from a buy to hold.

Bristol-Myers Squibb And WuXi PharmaTech Announce Collaboration For A New Analytical And Stability Testing Facility

Bristol-Myers Squibb And WuXi PharmaTech Announce Collaboration For A New Analytical And Stability Testing Facility

Bristol-Myers Squibb Company (NYSE: BMY) and WuXi PharmaTech (NYSE: WX) today announced that they have entered a strategic partnership to conduct stability studies of small-molecule new chemical entities to...

10 Pharma Stocks With Upside

10 Pharma Stocks With Upside

These pharma stocks are poised for an upside of at least 28%, according to analysts' estimates.

5 Drug Stocks With Upside Potential of 25%

5 Drug Stocks With Upside Potential of 25%

These five firms could return 16% to 25% over the next 12 months based on analysts' consensus estimates.

Schlumberger - Upgrades & Downgrades

Schlumberger - Upgrades & Downgrades

TheStreet Ratings released rating changes on 24 U.S. common stocks for November 10, 2010. Seven stocks were downgraded and 17 stocks have been upgraded by our stock model.

It Pays to Trade Like an Activist Investor

The stocks that activist investors target end up outperforming the market by an impressive 21.6 percentage points annually, a study shows.

Charles River And WuXi File Revised Investor Presentation

Charles River Laboratories International, Inc.(NYSE: CRL) and WuXi PharmaTech (NYSE:WX) today announced that they have issued an updated investor presentation in connection with Charles River’s proposed ...

Kendall Law Group Investigates WuXi PharmaTech (Cayman) Inc. For Shareholders

Kendall Law Group, a national securities firm, is investigating WuXi PharmaTech (Cayman) Inc.

Charles River to Buy WuXi PharmaTech

Charles River Laboratories agreed to buy WuXi PharmaTech in a cash-and-stock deal valued at about $1.6 billion.

Charles River Laboratories And WuXi PharmaTech To Combine, Creating The First Global CRO Offering Fully Integrated Early-Stage Drug Development Services To Clients Worldwide

Charles River Laboratories International, Inc. (NYSE: CRL), a leading global provider of research models and associated services and of preclinical drug development services, and WuXi PharmaTech (Cayman) Inc.

Biostar: Best Small-Cap Pharma Stock

Biostar has recently applied for a Nasdaq listing and could be a double or triple once it trades on the Nasdaq.

An Insanely Strong Market

Despite an ongoing bearish divergance, it doesn't seem that the bear has enough power to bring down this mighty market.

'Mad Money Lightning Round': Fabulous Johnson & Johnson

The company is doing everything right, Cramer says.

Friday's Asia ADR Recap

These stocks from India and China are making moves and news in the U.S

Health Winners & Losers: Lincare

Lincare lifts on an upgrade.

Wednesday's Winners & Losers: U.S. Airways

Wednesday's Winners & Losers: U.S. Airways

Shares are up 13% as oil prices fell to two-week lows.